15813-07-7

Usage

Uses

Used in Pharmaceutical Industry:
5(4)-IODO-4(5)-METHYL-IMIDAZOLE is used as a building block in the synthesis of organic compounds for the development of pharmaceutical drugs. Its unique structure and reactivity contribute to the creation of new drug candidates with potential therapeutic applications.
Used in Chemical Industry:
In the chemical industry, 5(4)-IODO-4(5)-METHYL-IMIDAZOLE serves as a precursor in the production of various chemical compounds. Its versatility allows for the synthesis of a range of products with different applications.
Used in Research and Development:
5(4)-IODO-4(5)-METHYL-IMIDAZOLE is utilized in research and development processes due to its unique properties. Scientists and researchers explore its potential applications and interactions with other compounds to discover new uses and enhance existing ones.
It is crucial to handle 5(4)-IODO-4(5)-METHYL-IMIDAZOLE with care and adhere to proper safety protocols to minimize potential hazards associated with its use.

Upstream product

• 822-36-6 4-methyl-1H-imidazole 
• 149510-85-0 2,5-diiodo-4-methyl-1H-imidazole 

Downstream Products

• 198205-84-4 4-iodo-5-methyl-1-trityl-1H-imidazole 
• 1039762-69-0 5-iodo-4-methyl-1-trityl-1H-imidazole 

Relevant academic research and scientific papers

FACTOR XIa INHIBITORS

The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma Kallikrein.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

Ionic liquid iodinating reagent for mild and efficient iodination of aromatic and heteroaromatic amines and terminal alkynes

Hexamethylene bis(N-methylimidazolium) bis(dichloroiodate) (HMBMIBDCI), an ionic liquid iodinating reagent, have been prepared and characterized. Its ability to perform iodination reactions with a variety of substrates has been explored. In general, iodination reactions of aromatic and heteroaromatic amines proceed with good yields in the absence of solvent. Reactions of terminal alkynes in the presence of 1,8-diazabicyclo [5.4.O] undec-7-ene and tetrahydrofuran have been investigated as well.